Raymond P. Lin

Raymond P. Lin

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications

NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants.

NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants.

Journal: Human vaccines & immunotherapeutics
Published: May 05, 2026

Vaccines in Dermatology-Present and Future: A Review.

Vaccines in Dermatology-Present and Future: A Review.

Journal: Vaccines
Published: December 10, 2024

Genotypic diversity and antimicrobial resistance phenotype of carbapenem-resistant and carbapenem-susceptible Acinetobacter species isolates.

Genotypic diversity and antimicrobial resistance phenotype of carbapenem-resistant and carbapenem-susceptible Acinetobacter species isolates.

Journal: Pathology
Published: October 08, 2024

A Review of Regulatory Frameworks for Biobanking in Southeast Asia.

A Review of Regulatory Frameworks for Biobanking in Southeast Asia.

Journal: Biopreservation and biobanking
Published: September 09, 2024

First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial.

First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial.

Journal: EBioMedicine
Published: March 01, 2024

Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance.

Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance.

Journal: BMC infectious diseases
Published: February 23, 2024

Author Correction: Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave.

Author Correction: Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave.

Journal: Scientific reports
Published: January 17, 2024

Advancing pathogen genomics in resource-limited settings.

Advancing pathogen genomics in resource-limited settings.

Journal: Cell genomics
Published: December 20, 2023

Whole genome characterization of Trichophyton indotineae isolated in Singapore.

Whole genome characterization of Trichophyton indotineae isolated in Singapore.

Journal: Medical mycology
Published: December 11, 2023

Implementation of national whole-genome sequencing of Mycobacterium tuberculosis, National Public Health Laboratory, Singapore, 2019-2022.

Implementation of national whole-genome sequencing of Mycobacterium tuberculosis, National Public Health Laboratory, Singapore, 2019-2022.

Journal: Microbial genomics
Published: November 27, 2023

Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial.

Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial.

Journal: Vaccine
Published: September 07, 2023

Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave.

Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave.

Journal: Scientific reports
Published: June 20, 2023
Showing 1-12 of 97

Last Updated: 09/26/2026